Expression of hypoxic signaling markers in head and neck squamous cell carcinoma and its clinical significance

European Archives of Oto-Rhino-Laryngology

Volumn 272, Issue 1, 2015, Pages 219-228

  Choi, Hyo Geun ^a   Kim, Jin Soo ^b   Kim, Ki Hwan ^b   Kim, Kwang Hyun ^b   Sung, Myung Whun ^c   Choe, Ji Young ^b   Kim, Ji Eun ^b   Jung, Young Ho ^b  

^a Hallym University   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Alpha subunit; Biological; HSP70 heat shock proteins; HSP90 heat shock proteins; Hypoxia inducible factor 1; IGF Type 1; Receptor; Tumor markers; Vascular endothelial growth factor A

Indexed keywords

TUMOR MARKER;

ADULT; AGED; BIOSYNTHESIS; CELL HYPOXIA; FEMALE; HEAD AND NECK TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84940035951     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-014-2954-1     Document Type: Article

References (41)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300
2. Ragin CC, Modugno F, Gollin SM (2007) The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 86(2):104–114
3. Pivot X, Felip E, ESMO Guidelines Working Group (2008) Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19(Suppl 2):ii79–ii80
4. Isa AY, Ward TH, West CM, Slevin NJ, Homer JJ (2006) Hypoxia in head and neck cancer. Br J Radiol 79(946):791–798
5. Tsai YP, Wu KJ (2012) Hypoxia-regulated target genes implicated in tumor metastasis. J Biomed Sci 19:102
6. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721–732
7. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH, Semenza GL (2001) Expression of hypoxia-inducible factor-1alpha: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61(7):2911–2916
8. Kong X, Lin Z, Liang D, Fath D, Sang N, Caro J (2006) Histone deacetylase inhibitors induce VHl and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol 26(6):2019–2028
9. Han JY, Oh SH, Morgillo F, Myers JN, Kim E, Hong WK, Lee HY (2005) Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. J Natl Cancer Inst 97(17):1272–1286
10. Goloudina AR, Demidov ON, Garrido C (2012) Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett 325(2):117–124
11. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G (2006) Heat shock proteins 27 and 70: ANTI-apoptotic proteins with tumorigenic properties. Cell Cycle 5(22):2592–2601
12. Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggio MA, Procaccini M, Ferrari F, De Rosa G, Altieri DC (2003) Survivin expression in oral squamous cell carcinoma. Br J Cancer 89(12):2244–2248
13. Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10(2):86–103
14. Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2(10):795–803
15. Qu JT, Wang M, He HL, Tang Y, Ye XJ (2012) The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review. J Cancer Res Clin Oncol 138(5):819–825
16. Slomiany MG, Black LA, Kibbey MM, Day TA, Rosenzweig SA (2006) IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun 342(3):851–858
17. Lukits J, Timar J, Juhasz A, Dome B, Paku S, Repassy G (2001) Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization. Otolaryngol Head Neck Surg 125(1):18–22
18. Repassy G, Forster-Horvath C, Juhasz A, Adany R, Tamassy A, Timar J (1998) Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res 4(1):14–21
19. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474
20. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47(1):207–214
21. Ishibashi H, Suzuki T, Suzuki S, Moriya T, Kaneko C, Takizawa T, Sunamori M, Handa M, Kondo T, Sasano H (2003) Sex steroid hormone receptors in human thymoma. J Clin Endocrinol Metab 88(5):2309–2317
22. Park ST, Song MJ, Park JS, Hur SY, Lee CW (2011) Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients. World J Surg Oncol 9:72
23. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O’Sullivan B, Kenny LM, McArthur GA (2012) Prognostic significance of P16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 28(27):4142–4148
24. Richard DE, Berra E, Pouyssegur J (1999) Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun 266(3):718–722
25. Koukourakis MI, Giatromanolaki A, Sivridis E, Pastorek J, Karapantzos I, Gatter KC, Harris AL, Tumour and Angiogenesis Research Group (2004) Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 59(1):67–71
26. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Turley H, Talks K, Gatter KC, Harris AL (2002) Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 53(5):1192–1202
27. Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E (2003) Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97(6):1573–1581
28. Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441(7092):437–443
29. Fillies T, Werkmeister R, van Diest PJ, Brandt B, Joos U, Buerger H (2005) HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer 5:84
30. Lee SS, Tsai CH, Ho YC, Chang YC (2008) The upregulation of heat shock protein 70 expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Oncol 44(9):884–890
31. Gandour-Edwards R, Trock BJ, Gumerlock P, Donald PJ (1998) Heat shock protein and p53 expression in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 118(5):610–615
32. Thiel UJ, Feltens R, Adryan B, Gieringer R, Brochhausen C, Schuon R, Fillies T, Grus F, Mann WJ, Brieger J (2011) Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS. J Oral Pathol Med 40(5):369–379
33. Farzanehpour M, Soleimanjahi H, Hassan ZM, Amanzadeh A, Ghaemi A, Fazeli M (2013) HSP70 modified response against HPV based tumor. Eur Rev Med Pharmacol Sci 17(2):228–234
34. Lin CT, Hung CF, Juang J, He L, Lin KY, Kim TW, Wu TC (2003) Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies and antitumor effects of HPV-16 E7-expressing Sindbis virus replicon particles. Mol Ther 8(4):559–566
35. Guo F, Rocha K, Bali P, Pranpat M, Fiskus W, Boyapalle S, Kumaraswamy S, Balasis M, Greedy B, Armitage ES, Lawrence N, Bhalla K (2005) Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer Res 65(22):10536–10544
36. Kyzas PA, Cunha IW, Ioannidis JP (2005) Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. Clin Cancer Res 11(4):1434–1440
37. Chen M, Cai E, Huang J, Yu P, Li K (2012) Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 21(7):1126–1134
38. Pengchong H, Tao H (2011) Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma. Eur J Gynaecol Oncol 32(6):660–664
39. Spiliotaki M, Markomanolaki H, Mela M, Mavroudis D, Georgoulias V, Agelaki S (2011) Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor effect. Lung Cancer 73(2):158–165
40. Zhang C, Hao L, Wang L, Xiao Y, Ge H, Zhu Z, Luo Y, Zhang Y, Zhang Y (2010) Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer. BMC Cancer 10:184
41. Kuramoto H, Hongo A, Liu YX, Ojima Y, Nakamura K, Seki N, Kodama J, Hiramatsu Y (2008) Immunohistochemical evaluation of insulin-like growth factor I receptor status in cervical cancer specimens. Acta Med Okayama 62(4):251–259